Published in Oncogene on March 27, 2017
Hippo pathway in lung development. J Thorac Dis (2017) 0.75
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol (2001) 31.56
Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell (2005) 15.06
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev (2007) 13.05
TEAD mediates YAP-dependent gene induction and growth control. Genes Dev (2008) 9.88
Early restriction of peripheral and proximal cell lineages during formation of the lung. Proc Natl Acad Sci U S A (2002) 5.54
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev (2010) 5.38
The molecular basis of lung morphogenesis. Mech Dev (2000) 4.87
Major effect on susceptibility to urethan-induced pulmonary adenoma by a single gene in BALB/cBy mice. J Natl Cancer Inst (1983) 4.72
Inducible gene targeting in mice using the Cre/lox system. Methods (1998) 4.61
TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J (2000) 4.55
Isolation and primary culture of murine alveolar type II cells. Am J Respir Cell Mol Biol (1996) 3.77
p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat Genet (2007) 3.30
Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ. Am J Physiol Renal Physiol (2008) 2.24
Compensatory roles of Foxa1 and Foxa2 during lung morphogenesis. J Biol Chem (2005) 2.15
Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med (2010) 2.05
Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci (2010) 2.04
HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology (2009) 2.02
TAZ interacts with TTF-1 and regulates expression of surfactant protein-C. J Biol Chem (2004) 1.98
Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion. Proc Natl Acad Sci U S A (2008) 1.90
Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J Clin Invest (2007) 1.86
Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res (1992) 1.86
TAZ is a novel oncogene in non-small cell lung cancer. Oncogene (2011) 1.85
Lung cancer and lung stem cells: strange bedfellows? Am J Respir Crit Care Med (2006) 1.79
Genetic disorders influencing lung formation and function at birth. Hum Mol Genet (2004) 1.75
Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat Genet (1995) 1.71
The mutational landscapes of genetic and chemical models of Kras-driven lung cancer. Nature (2014) 1.57
Hair follicle stem cells provide a functional niche for melanocyte stem cells. Cell Stem Cell (2011) 1.48
Humanization of autoantigen. Nat Med (2007) 1.47
HD4, a 180 kDa bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome. J Biochem (1993) 1.40
Primary type II alveolar epithelial cells present microbial antigens to antigen-specific CD4+ T cells. Am J Physiol Lung Cell Mol Physiol (2005) 1.29
Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis. Science (2016) 1.23
Temporal expression of alpha-smooth muscle actin and drebrin in septal interstitial cells during alveolar maturation. J Histochem Cytochem (2005) 1.17
Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice. J Clin Invest (2012) 1.16
Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice. Mol Carcinog (1996) 1.13
Prognostic significance of TAZ expression in resected non-small cell lung cancer. J Thorac Oncol (2012) 1.09
Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung. J Mol Cell Biol (2014) 1.08
Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ. Cell Rep (2015) 1.01
Transcriptional coactivator with PDZ-binding motif is essential for normal alveolarization in mice. Am J Respir Crit Care Med (2009) 0.99
Capturing the mammalian Hippo: elucidating its role in cancer. Cancer Sci (2013) 0.97
R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability. J Clin Oncol (2015) 0.94
Human MOB1 expression in non-small-cell lung cancer. Clin Lung Cancer (2007) 0.90
Hippo-Foxa2 signaling pathway plays a role in peripheral lung maturation and surfactant homeostasis. Proc Natl Acad Sci U S A (2013) 0.90
Collagen XVII/BP180: a collagenous transmembrane protein and component of the dermoepidermal anchoring complex. Clin Exp Dermatol (2005) 0.89
Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice. Proc Natl Acad Sci U S A (2015) 0.88
A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth. Dev Biol (2015) 0.85
Isolation and characterization of distal lung progenitor cells. Methods Mol Biol (2012) 0.85
Generation and characterization of a conditionally immortalized lung clara cell line from the H-2Kb-tsA58 transgenic mouse. In Vitro Cell Dev Biol Anim (2002) 0.82
Abnormal myocardial free fatty acid utilization deteriorates with morphological changes in the hypertensive heart. Jpn Circ J (2001) 0.82
Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor. J Biol Chem (2015) 0.78
A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L. Ann Oncol (2014) 0.91
Analysis of sebum lipid composition and the development of acneiform rash before and after administration of egfr inhibitor. Curr Oncol (2015) 0.76
Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small cell lung cancer. Ann Oncol (2017) 0.75
Tumor-infiltrating lymphocyte-mediated pleuritis followed by marked shrinkage of metastatic kidney cancer of the chest wall during nivolumab treatment. Ann Oncol (2017) 0.75
Two cases of late-onset secondary adrenal insufficiency after discontinuation of nivolumab. Ann Oncol (2017) 0.75
Nanoparticle albumin-bound paclitaxel can be useful agent to advanced primary mucinous carcinoma of the skin. J Eur Acad Dermatol Venereol (2014) 0.75